Prevalence, incidence and risk factors of tamoxifen-related non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Bo Ra LeeEun-Ae JungJeong-Ju YooSang Gyune KimCheon-Beom LeeYoung Seok KimSoung Won JeongJae Young JangSae Hwan LeeHong Soo KimBaek Gyu JunYoung Don KimGab Jin CheonPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
The use of tamoxifen was associated with increased risks in the incidence and prevalence of fatty liver, especially in patients with high BMI and hypercholesterolaemia.